Delivery Order SPE2DB25D3201-SPE2DB26FNNKH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cefazolin 2 G/50 ML with dextrose solution. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive set-aside award, issued under AmerisourceBergen Drug Corp's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solutions, valued at $1,228.56. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement to support federal medical supply needs, specifically for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solution, valued at $1,228.56, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,754.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-compete, non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This firm fixed-price delivery order, valued at $4,095.20, represents a competitively awarded contract with an ultimate completion date of June 2, 2025. The award was issued to the Corporate Office division of AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $10,147.43 delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML with dextrose solution, with a firm fixed price and an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextrose solution, a commonly used antibiotic pharmaceutical product. The contract was competitively awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, and reflects a firm fixed-price arrangement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.75 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML in dextrose solution. The contract employs firm fixed price terms and is scheduled for ultimate completion on July 30, 2025, just one day after the award date of July 29, 2025. This delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNKHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,921.10 to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solution. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Cefazolin is a broad-spectrum antibiotic commonly used in military and federal healthcare settings for surgical prophylaxis and infection treatment, representing the type of critical medical commodity routinely procured through the DLA's pharmaceutical supply chain to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/16/25 |